Study guide
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols
Key Takeaways Explain This Topic AI
A facility registry measures the diagnosis, treatment and outcomes of its own analytic caseload; a central registry measures cancer incidence and trends for every resident of a defined geographic population.
Specialty registries focus on a particular site, age group, treatment study or population, such as clinical trial, pediatric or federal (for example, VA) cancer registries.
CoC now uses the term "protocol" instead of "policy and procedure"; every protocol written to meet a CoC standard must be approved by the cancer committee.
CoC Standard 4.3 applies to contracted and registry-service-company abstractors exactly as it applies to employees: abstracting by an ODS, or under a documented ODS supervision plan.
A hospital that outsources abstracting must have a HIPAA Business Associate Agreement with the vendor before granting access to protected health information.
Last updated: September 2026
Why registry type matters
Many exam questions hinge on who is collecting the data and why . A question about follow-up rates, Class of Case or cancer conferences is set in a facility registry . A question about incidence, death clearance or deduplication across hospitals is set in a central registry . The purpose of the registry decides which cases it includes, which standards it follows and how its data are used.
The three registry types
Feature Facility (hospital-based) registry Central (population-based) registry Specialty registry
Who is included Patients diagnosed and/or treated at the facility; reportable cases, with analytic cases (Class of Case 00–22) at the core All reportable cancers in residents of a defined area (state, province, region), wherever they were diagnosed or treated A defined subset: one site (for example, a brain tumor registry), one age group (pediatric), a research study or trial, or a population such as veterans
Primary purposes Evaluate patient care and outcomes, support accreditation (CoC, NAPBC, NAPRC), cancer committee and conference work, program planning, research Incidence, prevalence, mortality and survival statistics; cancer control planning; cluster investigations; research Detailed clinical, treatment or research data beyond what the standard abstract holds
Main standards STORE (for CoC programs), state reporting rules, Solid Tumor Rules, AJCC and other staging systems NAACCR standards, NPCR and/or SEER requirements, state law Study protocol or sponsor requirements, plus national coding standards
Signature activities Casefinding, abstracting, staging, annual follow-up, NCDB/RCRS submission Record linkage, consolidation into one record per tumor, death clearance and follow-back, geocoding, data release Protocol-specific data collection and outcomes tracking
Central registry functions in more detail
Central registries receive multiple reports for the same tumor from hospitals, pathology laboratories, physician offices, radiation centers and other states. They must:
Link records that belong to the same person using deterministic (exact-match) and probabilistic (weighted, likelihood-based) matching on name, date of birth, SSN, sex and address.
Consolidate the reports into one record per tumor, choosing the best value for each item. The NCRA Code of Ethics recognizes that consolidation may change inaccurate or incomplete submitted data.
Conduct death clearance by matching against state death certificates, then follow back to facilities and physicians for unmatched cancer deaths.
Share data with other states through interstate data exchange agreements, so residents diagnosed across state lines are counted in their home state.
Submit to NPCR and/or SEER and to NAACCR for certification and national statistics.
How a hospital registry is organized
A hospital registry usually sits in Health Information Management, the cancer service line, or quality management. Wherever it sits, it answers to two lines of authority:
Administrative: a department director or administrator handles budget, staffing, space and performance evaluations.
Programmatic (CoC-accredited programs): the cancer committee directs the program, approves protocols and reviews registry quality control results (Standards 2.1 and 6.1).
A registry staff typically includes ODS abstractors, casefinding and follow-up staff, and a registry manager. CoC requires an ODS on the cancer committee, and an ODS may serve as the Cancer Conference Coordinator and/or the Cancer Registry Quality Coordinator.
Written protocols and procedure manuals
The CoC glossary lists "policy and procedure" as retired terminology and replaces it with protocol : "a structured and consistent process crafted by the cancer program to help implement the required compliance criteria for specific CoC standards." All protocols must be approved by the cancer committee. Examples include the multidisciplinary cancer case conference protocol (Standard 2.5) and the cancer registry quality control protocol (Standard 6.1).
Beyond what CoC requires, NCRA's role delineation study lists "Maintain up-to-date policies and procedures" as a registry task. A well-run registry keeps a procedure manual that documents:
The reference date and the case eligibility rules in use (CoC-required, state-required and reportable-by-agreement cases).
Casefinding sources , how often each is screened, and how the suspense file is managed.
Accession and sequence number conventions, abstracting workflow, and the current versions of reference manuals.
Follow-up methods and schedules.
Quality control methods, including who reviews what and how errors are corrected.
Confidentiality and data release , including the approval route for internal and external data requests.
Data security, backup and retention .
Update the manual whenever standards change. New STORE, Solid Tumor Rules and staging releases arrive at least once a year.
Budgeting basics
Operating expenses (OPEX) recur every year: salaries and benefits, software licenses and maintenance, reference subscriptions, NCRA dues, and continuing education and travel. Budget CE time so each ODS can earn the 20 CE credits per two-year cycle (including 4 Category A credits and, over four years, 8 in-person CEIP credits) that the credential requires.
Capital expenses (CAPEX) are large, long-lived purchases depreciated over several years, such as servers or a major registry software replacement.
Showing the value of the registry to administrators means pointing to accreditation, benchmarking, community needs assessment, clinical trial screening and service-line planning.
Contracting for abstracting services
When a backlog or vacancy leads a hospital to use a contract abstracting service:
Apply CoC Standard 4.3 exactly as for employees. Abstracting is done by an ODS, or by a non-ODS working under the program's documented ODS supervision plan within the three-year credentialing window. Standard 4.3 explicitly covers contract and registry-service-company staff.
Execute a Business Associate Agreement under 45 CFR 164.502(e) and 164.504(e) before any access to protected health information.
Write measurable service levels into the contract: turnaround time, expected volume, the accuracy threshold on re-abstracting review, correction of errors at no charge, and secure remote access (for example, virtual desktop access with no local storage).
Keep quality control in-house. Contract cases are included in the program's Standard 6.1 quality control review, and an ODS may not review their own cases.
Exam traps
Don't answer "policy and procedure manual annual approval required by CoC." The 2020 standards talk about protocols approved by the cancer committee, tied to specific standards.
A central registry is not "just a bigger hospital registry." Its denominator is a population, and it must deduplicate and consolidate reports from many sources.
Contract staff follow the same credential rule as employees. Outsourcing does not bypass CoC Standard 4.3.